Document Detail

Atrial fibrillation (acute onset).
MedLine Citation:
PMID:  25430048     Owner:  NLM     Status:  In-Data-Review    
INTRODUCTION: Acute atrial fibrillation is rapid, irregular, and chaotic atrial activity of recent onset. Various definitions of acute atrial fibrillation have been used in the literature, but for the purposes of this review we have included studies where atrial fibrillation may have occurred up to 7 days previously. Risk factors for acute atrial fibrillation include increasing age, cardiovascular disease, alcohol, diabetes, and lung disease. Acute atrial fibrillation increases the risk of stroke and heart failure. The condition resolves spontaneously within 24 to 48 hours in more than 50% of people; however, many people will require interventions to control heart rate or restore sinus rhythm.
METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions to prevent embolism, for conversion to sinus rhythm, and to control heart rate in people with recent-onset atrial fibrillation (within 7 days) who are haemodynamically stable? We searched: Medline, Embase, The Cochrane Library, and other important databases up to April 2014 (Clinical Evidence reviews are updated periodically; please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 26 studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review, we present information relating to the effectiveness and safety of the following interventions: amiodarone, antithrombotic treatment before cardioversion, atenolol, bisoprolol, carvedilol, digoxin, diltiazem, direct current cardioversion, flecainide, metoprolol, nebivolol, propafenone, sotalol, timolol, and verapamil.
Gregory Y H Lip; Stavros Apostolakis
Related Documents :
7524628 - Susceptibility of c5b-9(m) to postmortem changes.
25285608 - Isolating primary melanocyte-like cells from the mouse heart.
25475448 - Canadian cardiovascular society/canadian association of interventional cardiology/canad...
25160238 - Correlation between symbolic dynamics analysis indexes and neurohormonal and functional...
10903648 - Low grade inflammation and coronary heart disease: prospective study and updated meta-a...
23738998 - Ginsenoside rd for acute ischemic stroke: translating from bench to bedside.
Publication Detail:
Type:  Journal Article     Date:  2014-11-27
Journal Detail:
Title:  Clinical evidence     Volume:  2014     ISSN:  1752-8526     ISO Abbreviation:  Clin Evid (Online)     Publication Date:  2014  
Date Detail:
Created Date:  2014-11-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101294314     Medline TA:  Clin Evid (Online)     Country:  England    
Other Details:
Languages:  eng     Pagination:  -     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prognostic impact of the TP53 rs1625895 polymorphism in DLBCL patients.
Next Document:  Temperature and pressure tuneable swollen bicontinuous cubic phases approaching nature's length scal...